STUDIES ON TYPE II PROGESTERONE RECEPTOR MCFJ CELLS D. E. Saunders, C. Christensen, and S. C. Brooks Department of Biochemistry, Detroit, MI 48201, USA
Wayne
State University
IN
School of Medicine,
Corresponding author: 5. C. Brooks Received Revised
July 17, 1987 February
5, 1988
ABSTRACT These experiments demonstrate for the first time the existence of a Type II progesterone receptor (RpII) in MCF-7 human breast cancer cells. RpII was shown to have a lower affinity for tritiated progesterone (C3HlPg) (Kd > 13 nM) than classical Rp (Kd < 3 nM). RpII was detected Ey cytosolic, nuclear, and whole- cell assays of MCF-7 cells. Scatchard analysis of C3HlPg binding data revealed that classical Rp but not RpII could be recompartmentalized from the cytosolic to the nuclear pool by treating cells 1 h at 37OC with 1 uM Pg. RpII levels were shown to be increased more than two-fold by growing MCF-7 cells for 4 days in 10 nM estradiol (E2) plus 100 nM Pg when compared to either untreated cells or to cells treated with only E2. INTRODUCTION Under in
this
a
variety of growth and treatment regimens carried out
laboratory, very few cases were seen where the cytosolic
compartment
of
progesterone cells
with
compartment grown
in
(Pg) 1
PM
receptor Pg
(1
breast (Rp).
h)
failed
cancer For to
cells was devoid of
example, pulsing MCF-7 deplete
the cytosolic
Furthermore, cells
steroid-free media (e.g., Chemically Defined Media, CDM
observations).
52/3
human
of Rp (unpublished observations).
possessed
[II)
STEROIDS
MCF-7
appreciable This
September
1988
levels
of
Rp
(unpublished
was unexpected, as estradiol (Ep) has been
(249-263)
249
250
Saundersetal:TYPEIIPROCESTERONE
demonstrated
to
be
addition,isolated
for
necessary
nuclei
from
MCF-7
synthesis
cells
of
Rp.
RECEPTOR
In
grown in CDM showed
appreciable C3HlPg binding (unpublished observations). above observations were strikingly similar to the Type II
The
estrogen-binding uterus.
of
a
lower
classical Re
Clark
et --
al
121 had observed in the rat
These investigators demonstrated a form of receptor that
possessed the
that
was
present
Kd (30 nM) and a higher binding capacity than
form
of estrogen receptor (Re).
designated
in
both
Type
the
recompartmentalized
II Re (ReII).
cytosolic
by
E2
and
[2].
This novel class
ReII was shown to be
nuclear
pools but was not
Subsequent studies have shown
an association between ReII and uterine growth [3].
of
The
cytosolic
the
report
extracted
in
by
from
homogenization
and
nuclear compartments are defined in terms
Welshons
the
et al C41. --
nucleus
buffer.
the
nuclei
the
hypotonic
(10
mM
TRIS)
These receptors are subsequently isolated
the 100,000 g supernatant.
in
by
Cytosolic receptors are
Nuclear receptors remain localized homogenization
during
and
subcellular
fractionation. In
view
of
and
the
experiments
were
cells
high-capacity
the similarities between C3HlPg binding in MCF-7
form
observations
on
ReII
carried
to
determine
of
Rp
out
(RpII)
by
exists
Clark
and
et --
al
CZI,
if a low-affinity, to
explore
its
characteristics.
STEROIDS 52/3
September 1988
Saundersetal:TYPEIIPROCESTERONE
RECEPTOR
251
EXPERIMENTAL Cl 2 6 7-3H1Pg (1::) Ci/mmol) was.purchased Purification of the frozm;d Nucieir' (Boston . labeled Pg was performed on ins&t thin layer chromatographic sheets (S. A. Gelman Instrum;;tI)Co., Ann Arbor, MI) with ethyl cyclohexane: acetate as developing solvents. Unlabeled standards were visualized by spraying with a mixture of 20 mL glacial acetic acid, 0.2 mL anisaldehyde, and 0.4 mL heating concentrated sulfuric acid, followed by the chromatographic strip at 110% for 10 min. Cell Culture. MCF-7 cells (a gift of Dr. H. Soule, Michigan were grown in T-75 flasks using Eagle's Cancer Foundation Minimal Essential"')Media (MEM) supplemented with 10% dextran-coated charcoal stripped Donor Calf Serum (Flow Laboratories), 50 pg/mL insulin, L-glutamine, and 0.1 ug/mL gentamycin sulfate (Sigma). Dextran-Coated Charcoal Treatment of Calf Serum. Aliquots (1 mL) of dextran-coated charcoal solution (DCC, 10 parts charcoal to 1 part dextran) were centrifuged 10 min at 1500 g and the Donor Calf Serum (25 mL) was added to the supernatant decanted. pellets and the tubes vortexed vigorously. The tubes were then centrifuged 10 min at 1500 g and the supernatant recovered. This procedure was repeated 2 additional times followed by filtration The stripping procedure was sterilization of the calf serum. carried out at 250C. Assay of Cytosolic Rp. Post-confluent cells were washed twice with 0 9% saline and once with TED buffer (10 nM TRIS, 1.5 mM ethylenediiminetetraacetate CEDTAI, 3 mM dithiothreitol [DTTI and 3 IIM cortisol, pH 7.4 at 4OC). Homogenization of harvested cells was accomplished with 15 strokes in a Dounce homogenizer with a tight-fitting pestle followed by centrifugation of the homogenate at 100,000 g for 1 h. Two hundred microliters of the supernatant (cytosolic fraction) were added to tubes containing [3H]Pg + unlabeled Pg (200-fold excess). The final concentrarions of C3HlPg ranged from 0.5 nM to 30 nM. The mixture was incubated initially for 2 h at 4oC and then for an additional 1 h in the presence of 30% glycerol. Unbound C3HlPg was removed by the addition of 0.4 mL DCC solution (10 mM TRIS, 1.5 mM EDTA, 30% glycerol, 0.5% charcoal, 0.05% dextran, pH 7.4 incubated for 30 min with occasional vortexing, at 4OC), followed by spinning for 15 min at 1500 g. The supernatant (0.25 mL) was counted in 10 mL scintillation cocktail. Binding data were analyzed by the method of Scatchard C61 with application of the Pennock 171 correction technique for multiple classes of
STEROIDS
52/3
September 1988
Saunders et al: TYPE
252
II PROGESTERONE
RECEPTOR
binding. This entailed plotting the data points, then visually both the low-affinity and estimating straight lines for high-affinity components. Radial lines were then drawn beginning at the plot origin and extending through both the estimated component lines and the curvilinear line fit to the data points. The estimated lines for the two binding components were then adjusted until the distance from the origin along each radial to the estimated line equalled the distance from the estimated line to curve fit along the data points. This method yields a mathematical estimate of both the high-affinity (RpI) binding component and the low-affinity (RpII) component and was applied DNA was quantified using to all curvilinear Scatchard plots. Burton's diphenylamine assay C81. Assay of Nuclear Rp. MCF-7 cells were grown and harvested as described above. Detection of nuclear Rp was performed according to the method of Walters et al [9], with minor modifications. Briefly, nuclear fractions fioiii-homogenizedcells were washed 3 times by centrifugation through 0.25 M sucrose buffer (10 mM TRIS, 2.5 mM CaC12, 0.25 M sucrose, pH 7.6 at 4oC). Aliquots (0.4 mL) of the nuclear suspension were incubated overnight in and 3 mM TGC buffer (10 mM TRIS, 30% glycerol, 2.5 mM CaCl DTT, pH 7.4 at 4oC) containing concentrations of f3HlPg (+ a 200-fold excess of unlabeled Pg) ranging from 0.5 to 30 TiM. Maximum [3H]Pg exchange occurred under these conditions ClOl. After incubation, 0.2 mL of a 50% hydroxylapatite suspension in TGC was added, followed by a 10 min incubation and a 10 min centrifugation at 1500 g. The pellets were then washed 3 times Bound [3H]Pg was eluted by centrifuging throuh TGC buffer. overnight at 4oC with ethanol and counted. Whole Cell Assay of Rp. Post-confluent cells were washed 3 times with MEM and harvested in MEM. To minimize cell rupture, cells were syringed loose using a large bore (14 gauge) cannula. Greater than 80% of harvested cells were shown to be intact by A 0.4-mL aliquot of the cell suspension trypan blue exclusion. (approximately lo6 cells) was then incubated with C3HlPg (0.5 to 30 nM) + a 200-fold excess of unlabeled Pg for 2 h at 250C. The cells were then washed 3 times with ice-cold MEM to remove The remaining C3HlPg was eluted into extracellular steroid. 1.5 mL ethanol and the radioactivity monitored. RESULTS Pg MCF-7
Binding cells
to
in
MCF-7 Cells.
The exposure of E2 treated (nM)
concentrations of [3H]Pg ranging from 1 to 12 nM
STEROIDS
52/3
September
1988
Saunders et al: TYPE
yielded
II PROGESTERONE
RECEPTOR
253
a S-shaped saturation curve characteristic of two binding
sites (Figure 1).
I
I
3 nM
I
I
6
9
12
[3HlPg
Figure 1. Saturation curve of [3H]Pg binding in MCF-7 cells. Cell suspensions (lo7 cells per tube) were assayed as described in Materials and Methods. Pg cells
Binding produced
whether
in
Cytosol.
The
cytosol from E2-primed MCF-7
strikingly different Scatchard plots depending on
the culture had or had not been exposed to a l-h
pulse of
1 uM Pg at 370C (Figure 2). These [3HlPg
data
binding
from
the
c71
was
52/3
confirmation
components
and
of
the
applied of
September
to
the
Scatchard
the
two
C3HlPg
1988
high- and low-affinity
dissappearance
cytosol following a Pg pulse.
determinations
STEROIDS
provide
of
the RpI
The technique of Pennock plots
binding
to
give
components.
separate This
Saunderset al: TYPE
254
correction unpulsed dashes)
of
the
cells
non-linear
Scatchard
II PROGESTERONE
plot
RECEPTOR
of the data from
showed a high-affinity component (Figure ZA, long
which possessed a binding capacity of 1.2 fmol/ug DNA and
A. -Pg Scatchard
2
0 s
15-
z
12-
x 8 g z2 =
I
6
4
B. +Pg Scatchard
9630
"@@@-a..._
0
I
2
I
I
4
6
fmol [3HlPs/pg DNA
Figure 2. Detection of RpI and RpII in the cytosolic fraction of A. Scatchard Analysis of Pg binding in the cytosol MCF-7 cells. from Cells which were not administered Pg. Pennock correction indicates two binding sites one (long dashes) of high affinity (RpI) and one (short dashes) with lower affinity (RpII). 6. Scatchard analysis of cytosolic Pg binding following a pulse of Pg (luM, 1 h, 370C); only RpII is evident.
STEROIDS
52/3
September
1988
255
Saundersetal:TYPEIIPROCESTERONERECEPTOR
a
Kd
dashes) of
2.5 nM.
The lower affinity component (Figure 2A, short
possessed
a binding capacity of 2.9 fmol/ug DNA and a Kd
of
14
The curve in Figure 28 represents cytosolic Rp from
nM.
Pg-pulsed
Only the lower affinity RpII is seen.
cells.
components
in
Figures
2A
and
2B
appeared
possessing
similar binding capacities
to
be
The RpII identical,
(2.9 fmol/pg DNA in 2A and
3.1 fmol/pg DNA in 2B) and identical Kd's (14 nM in both). Examination examine in
the
The
nuclei
RpI
suspensions
with
low-affinity the
Scatchard C3HlPg of 4.8 RpII
and RpII in Isolated Nuclei.
To further
from
MCF-7 cells with and without a 1-PM Pg
and RpII levels were measured by incubating nuclear 0.5
Scatchard
unlike
RpI
compartmentalization of RpI and RpII, Rp was assayed
isolated
pulse.
of
plot
RpII
to
30
from
nM
C3HIPg
non-pulsed
component (Figure 3A).
high-affinity
+ unlabeled excess Pg. cells
showed
in
a
This nonlinear plot is
plot expected of RpI and resembles the
previously obtained for nuclear ReII C3l.
binding
only
The graph of
nuclei from cells which received a 1-UM pulse
Pg (Figure 3B) showed both a high-affinity RpI component (Kd = nM
from
replot,
component.
method
of Pennock C71) and a low-affinity
The Pennock replot suggested a Kd of 26 nM and a
binding
capacity
of
7.5
binding
capacity
of
the high-affinity RpI (1.0 fmol/pg DNA) was
strikingly
STEROIDS 52/3
similar
to
fmol/pg DNA for the nuclear RpII.
The
the amount of RpI which migrated from the
September 1988
Saunderset al:TYPE
256
cytosolic
compartment
experiments pulse
(Figure
will
cytosolic
(1.2 3)
effect
to
the
fmol/pg
further
DNA)
support
II PROGESTERONE
(Figure the
recompartmentalization
nuclear
pool
but
will
2).
RECEPTOR
These
premise that a Pg of
not
RpI
from
the
bring about the
nuclear "translocation" of RpII.
A. -Pg Scatchard
fmol [3H]Pg/pg DNA
20-I
B. +Pg Scatchard
0
3
6
9
12
li
fmol [3H]Pg/pg DNA
Nuclear Pg binding before and after a 1-LIMPg pulse. B. Pennock wchard plot analysis of control cells. corrected Scatchard analysis of Pg-pulsed cells.
STEROIDS
52/3
September 1988
Saunderset al: TYPE
II PROGESTERONE
Effects RpI
and
shown
E2
E2
[11,12].
levels, Cells E2
Pg
which
their
binding
in MCF-7
examined plot
48)
levels
fmol/ug cells).
cells was stimulated
after
experiments treated
a
with
better
4 days treatment of
were carried out using calf DCC to reduce its
steroid
indication of E2 and Pg effects.
for
from
total
cellular
RpI binding (Figure 4A). detected.
showed
E2-treated DNA
in
The
RpI
and
RpII.
The
the non-treated cells showed no evidence of
both
The RpI
and
control results
RpII binding (Kd = 13 nM)
plots
and
from
E2-treated
cells
RpII binding as indicated by
respective Kd's (3.1 and 16 nM). in
It has been
4 days in media containing DCC-stripped serum + 1 nM
however,
(Figure
RpII
been
giving
high-affinity was,
Pg Exposure of MCF-7 Cells on
by Whole Cell Assays.
RpII
These
had
grown
Scatchard
and
Experiments were undertaken to determine if
affected
thus
were
Pg
257
3 to 4 days of treatment in media supplemented with
cultures.
serum
E2
Determined
classical
and/or
cell
as
after
nM
Long-Term
RpII
that
5-fold 1
of
RECEPTOR
non-treated
The binding capacities of cells
were
similar
(9.5
cells and 8.4 fmol/pg DNA in E2-exposed show
that
4 days of E2 exposure induced
the binding capacity of RpI but had no net effect on RpII levels. The
effects
of
Ep
and
Pg
were
examined
after 4 days of
feeding
MCF-7 cells MEM plus DCC-stripped serum (control) (Figure
5A)
control
or
(Figure
STEROIDS
52/3
58).
media
supplemented
with
1 nM E2 and 0.1 IIM Pg
Scatchard plots from whole cell assays (Figure 5)
September
1988
Saundersetal:TYPEIIPROCESTERONE
258
indicated fmol/ug
the
DNA
absence of
dramatically control
of RpI in control cells but detected 11.3 in
RpI
E2-
plus
Pg-exposed
cells.
RpII was
elevated
by
E2 plus Pg exposure (36 fmol/ug DNA in
versus
83
fmol/ug
cells 12 -
s 5
RECEPTOR
DNA
in
Ep-
plus Pg-treated
A. Control
9-
J 8 $ z z a
630
I 3
0
I
I
1
6
9
12
fmol [3H]Pglpg DNA
121
B. E2 treared
9-
6\ \ 3-A \_ \
0 0
3
I
I
1
6
9
12
fmol [3H]Pg/pg DNA Effects of a &day exposure of MCF-7 cultures to I nM cellular RpI and RpII. A. Scatchard analysis of RpI in control cells. B. Pennock-corrected Scatchard analysis Of E2-treated cells.
STEROIDS 52/3
September 1988
Saundersetal:TYPEIIPROCESTERONERECEPTOR
cells).
The
Pg-treated
cells
overestimate
higher
apparent
(32.5
caused
by
259
Kd
RpII
for
in
the
E2-plus
versus 17 nM in control cells) may be an the cooperativity of RpII in the nuclear
pool (see Figure 3A).
s
5 -3
24loA. Control
0
10
20
30
40
50
fmol [3H]Pg/pg DNA o^
24-
B.
no
L, 0
30
60
EZ+Pg treated
I 90
I 150
I 120
fmol [3H]Pg/pg DNA Effect of Pg binding of E2 (1 nM) and Pg (0.1 uM) Figure 5. treatment of MCF-7 cells. A. Scatchard analysis of Pg binding in control cells. B. Pennock-corrected Scatchard analysis of E2-plus Pg-treated cells. The adding 2DDU-fold separate
STEROIDS 52/3
specificity
of RpII was examined in whole cell assays by
increasing
concentrations
excess) incubations
of
2-,
dihydrotestosterone
containing
September1988
(l-,
12
nM
20-, (DHT)
[3H]Pg.
200-, and It
E2
and to
required
260
Saunderset al:TYPE II PROGESTERONE
10.&M
DHT
(900-fold to
to
competitively
excess
decrease
Cortisol
[3H]Pg
did
not
block 50% of the binding of C3HIPg A 400-fold excess of Ep was required
DHT) .
of
RECEPTOR
to
binding
interfere
with
50% Pg
(also
binding to
competitively).
RpII since all
assays of cytosolic receptors contained 3vM of this steroid.
DISCUSSION The
data
specific
Pg
affinity
and
by
shown
presented
a
higher
the
this
previously levels
reported
presence
of
a
form
of
Rp
of
[3H]Pg An
(RpI).
conditions receptor
for to
binding
examination
of
the
stimulation of RpI has respond
treatments.
cellular
than that
predictably
For
to
example, its
increased by growing MCF-7 cells for 4 days in media with
for
in
days
nuclear
and
classical
were
increase
capacity
classical
supplemented 4
the
binding (RpII) in MCF-7 cells which displays a lower
compartmentalization shown
document
1 E2
nM E2 (Figure 4). plus
Pg-supplemented
RpI (Figure 5).
in pool
Furthermore, cells grown media
also showed an
RpI moved from the cytosolic to the
when cultures were pulsed 1 h with 1 IJM Pg (Figures
2 and 3). The
responses
of RpII to the above conditions were distinctly
different
from those of RpI.
cytosolic
and
the nuclear pools, a 1-uM Pg pulse failed to cause
recompartmentalization (Figures cells
in
2
Although RpII was found in both the
and
3).
of
RpII
Unlike
E2-supplemented
from
one
pool
into
the other
the RpI response, growth of MCF-7
media failed to increase the levels of
STEROIDS
52/3
September1988
Saundersetal:TYPEIIPROCESTERONE
RpII
(Figure
4).
Pg-supplemented
Although
(Figures
2
and
level of RpII These
observations
to
is,
ligand
rats
[12,131,
plus
in cellular
these
the
have
which
RpII
for
in
of
several
uterine and
ReII
respective
experiments
to
ReII
Ep
days
ReII
with
E2
These
[3].
RpII might serve similar
ligands.
However, unlike ReII
is not inhibited by reducing agents in
Studies have indicated that ReII is related
growth been
response
enhanced
inhibits of
responses
treated
that
their
uterine
the
increase
suggested
for
involvement
RpI
increase
E2-
a l-h E2 treatment recompartmentalized ReI
an
experiments.
findings
dramatic
in
suggest that Pg is capable of increasing the
and
sites,
the
induces
parallel
showed
functions
a
grown
only in E2-primed cultures.
ReII,
injections
these
5)
That
not
binding
E2
results
exposure. but
showed
261
cells
However,
media
RpII.
RECEPTOR
RpII
by
to
Ep
treatment
[3].
These
the discovery of an endogenous
binding of E2 to ReII [14].
The possible
in biologically important events remains to
be demonstrated. The
findings
studies
involving
compartment pool are
was
a
was
RpI.
here The
hold Kd
2.5 nM (Figure 2).
3 nM (Figure 3).
significantly
RpII.
presented
for
several implications for RpI
in
the
cytosolic
The Kd of RpI in the nuclear
Values obtained in
experiments which
higher than these may indicate the presence of
Furthermore residual Rp in the cytosolic compartment after
~-PM
STEROIDS 52/3
Pg
pulse
would
September1988
be
suspected of being RpII.
Likewise,
[3HlPg also
binding
may
indicate [3H]Pg
that
nuclei
by
cytosolic
Pg
that
pulsing it
The
low
and
of
RECEPTOR
non-Pg-treated
the
described Scatchard
cells herein
plots of
(< 6 nM) and high (> 10 nM) ligand
determination RpI
from
experiments
examination
both
allows
and
RpII,
at
isolated
RpII.
careful
binding
examined
in
represent
concentrations and
TYPEIIPROGESTERONE
Saundersetal:
262
of the presence of both RpI
RpII binding can be separated and
cells with 1 uM Pg.
In routine analyses of
is imperative that the concentrations of C3H]Pg
are kept below 6 nM. ACKNOWLEDGMENT This investigation was supported in part by PHS grant number CA-37387 awarded by the National Cancer Institute, DHHS. REFERENCES Studies on the cultivation 1. Higuchi K and Robinson RC (1973). of mammalian cell lines in a serum-free, chemically defined medium. In Vitro 9: 114-121. 2. Clark JH,Har;ain JW, and Upchurch S (1978). Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. i Biol Chem 253: 7630-7634. Two binding sites for 3. MarkavePich BM and Clark JH (1979). estradiol in rat uterine nuclei: Relationship to uterotrophic A::’ ~~~8-~~6rfki J (1984). Nuclear 4. ~~?%~~~' Wm localization of unoccupied estrogen receptors: Cytochalasin enucleation of GH3 cells. Nature 307: 747-749. 5. Soule HD, Vazquez J, LoAlbert S, and Brennan MJ A human cell line from a pleural effusion derived (1973). from a breast carcinoma. --J Nat1 Cancer Inst 51: 1409-1416. 6. Scatchard The attraction of proteins for small G (1949). Ann NY Acad Sci 51: 6601672. molecules and ions.' ---7. Pennock BE (1973). A calculator for finding binding parameters from a Scatchard plot. Anal Biochem 56: 306-309. 8. Burton K (1956). A study of the conditionsand mechanism of the diphenylamine reaction for the calorimetric estimation of deoxyribonucleic acid. -Biochem J 62: 315-322.
STEROIDS 52/3
September1988
Saunderset al:TYPE
9. 10. 11. 12.
13.
14.
STEROIDS
II PROGESTERONE
RECEPTOR
263
Walters MR, Hunziker W, and Clark JH (1980). Hydroxyapatite prevents nuclear receptor loss during the exchange assay of progesterone receptors. J Steroid Biochem 13: 1129-1132. Masters -Tm Examination of the nuclear Saunders DE. translocation of progesterone receptor in MCF-7 cells. Wayne State University 1983. Brooks SC, Hansen ER, Saunders DE, Battelli MG, and Shafie S.M (1984). Effects of growth on estrogen receptor levels in MCF-7 cells. Cancer Res 44: 3724-3729. Estrogen Horwitz KB, m T and McGuire WL (1978). control of progesterone receptor in human breast cancer: Role of estradiol and antiestrogen. Corombo~nd;;ri n~~~~~ef~3bE17~~11:~~01( Meyers SA, Lozon MM, Christensen C, and Brooks SC (198;). Induction'of porcin: uterine estrogen sulfotransferase activity by progesterone. Biol Reprod 28: 1119-1128. Markaverich BM, Roberts RR, Alejandra MA, and Clark JH. An endogenous inhibitor of 3H-estradiol binding in normal and malignant tissues (1984). -Cancer Res 44: 1515-1519.
52/3
September 1988